Early alterations of bile canaliculi dynamics and the rho kinase/myosin light chain kinase pathway are characteristics of drug-induced intrahepatic cholestasis

Abstract : Intrahepatic cholestasis represents 20%-40%of drug-induced injuries from which a large proportion remains unpredictable. We aimed to investigate mechanisms underlying drug-induced cholestasis and improve its early detection using human HepaRG cells and a set of 12 cholestatic drugs and six noncholestatic drugs. In this study, we analyzed bile canaliculi dynamics, Rho kinase (ROCK)/myosin light chain kinase (MLCK) pathway implication, efflux inhibition of taurocholate [a predominant bile salt export pump (BSEP) substrate], and expression of the major canalicular and basolateral bile acid transporters. We demonstrated that 12 cholestatic drugs classified on the basis of reported clinical findings caused disturbances of both bile canaliculi dynamics, characterized by either dilatation or constriction, and alteration of the ROCK/MLCK signaling pathway, whereas noncholestatic compounds, by contrast, had no effect. Cotreatment with ROCK inhibitor Y-27632 [4-(1-aminoethyl)-N-(4-pyridyl) cyclohexanecarboxamide dihydrochloride] and MLCK activator calmodulin reduced bile canaliculi constriction and dilatation, respectively, confirming the role of these pathways in drug-induced intrahepatic cholestasis. By contrast, inhibition of taurocholate efflux and/or human BSEP overexpressed in membrane vesicles was not observed with all cholestatic drugs; moreover, examples of noncholestatic compounds were reportedly found to inhibit BSEP. Transcripts levels of major bile acid transporters were determined after 24-hour treatment. BSEP, Na+-taurocholate cotransporting polypeptide, and organic anion transporting polypeptide B were downregulated with most cholestatic and some noncholestatic drugs, whereas deregulation of multidrug resistance-associated proteins was more variable, probably mainly reflecting secondary effects. Together, our results show that cholestatic drugs consistently cause an early alteration of bile canaliculi dynamics associated with modulation of ROCK/MLCK and these changes are more specific than efflux inhibition measurements alone as predictive nonclinical markers of drug-induced cholestasis.
Type de document :
Article dans une revue
Drug Metabolism and Disposition, American Society for Pharmacology and Experimental Therapeutics (ASPET), 2016, 44 (11), pp.1780--1793. 〈10.1124/dmd.116.071373〉
Liste complète des métadonnées

Littérature citée [62 références]  Voir  Masquer  Télécharger

https://hal-univ-rennes1.archives-ouvertes.fr/hal-01398437
Contributeur : Laurent Jonchère <>
Soumis le : lundi 23 octobre 2017 - 13:39:17
Dernière modification le : mercredi 16 mai 2018 - 11:23:31
Document(s) archivé(s) le : mercredi 24 janvier 2018 - 14:48:24

Fichier

Burbank - Early alterations of...
Fichiers produits par l'(les) auteur(s)

Identifiants

Citation

M.G. Burbank, Audrey Burban, Ahmad Sharanek, R.J. Weaver, Christiane Guguen-Guillouzo, et al.. Early alterations of bile canaliculi dynamics and the rho kinase/myosin light chain kinase pathway are characteristics of drug-induced intrahepatic cholestasis. Drug Metabolism and Disposition, American Society for Pharmacology and Experimental Therapeutics (ASPET), 2016, 44 (11), pp.1780--1793. 〈10.1124/dmd.116.071373〉. 〈hal-01398437〉

Partager

Métriques

Consultations de la notice

88

Téléchargements de fichiers

21